Shenyang Xingqi Pharmaceutical Co.,Ltd
SZSE:300573.SZ
150.38 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2014 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 534.09 | 345.82 | 358.854 | 419.393 | 398.91 | 286.56 | 245.583 | 403.7 | 298.614 | 301.959 | 257.568 | 307.982 | 255.165 | 207.2 | 219.334 | 232.541 | 154.097 | 82.71 | 132.368 | 158.699 | 140.381 | 110.986 | 94.233 | 134.869 | 113.182 | 88.921 | 78.786 | 98.44 | 96.087 | 86.694 | 79.546 | 94.136 | 86.823 | 78.595 | 62.237 |
| Cost of Revenue
| 120.251 | 83.613 | 92.614 | 85.629 | 93.205 | 68.865 | 66.089 | 78.454 | 61.363 | 59.767 | 59.087 | 60.55 | 57.869 | 47.74 | 54.429 | 59.472 | 44.831 | 26.297 | 36.134 | 39.477 | 40.504 | 28.935 | 22.686 | 34.886 | 33.4 | 28.387 | 23.786 | 25.617 | 25.821 | 18.717 | 18.994 | 20.788 | 20.99 | 23.335 | 19.091 |
| Gross Profit
| 413.838 | 262.206 | 266.241 | 333.764 | 305.705 | 217.696 | 179.494 | 325.246 | 237.251 | 242.192 | 198.481 | 247.433 | 197.295 | 159.46 | 164.905 | 173.069 | 109.266 | 56.413 | 96.234 | 119.223 | 99.877 | 82.051 | 71.546 | 99.984 | 79.782 | 60.534 | 55.001 | 72.822 | 70.266 | 67.976 | 60.552 | 73.348 | 65.833 | 55.26 | 43.147 |
| Gross Profit Ratio
| 0.775 | 0.758 | 0.742 | 0.796 | 0.766 | 0.76 | 0.731 | 0.806 | 0.795 | 0.802 | 0.771 | 0.803 | 0.773 | 0.77 | 0.752 | 0.744 | 0.709 | 0.682 | 0.727 | 0.751 | 0.711 | 0.739 | 0.759 | 0.741 | 0.705 | 0.681 | 0.698 | 0.74 | 0.731 | 0.784 | 0.761 | 0.779 | 0.758 | 0.703 | 0.693 |
| Reseach & Development Expenses
| 40.633 | 38.068 | 43.196 | 43.841 | 49.026 | 28.684 | 55.167 | 39.849 | 28.287 | 22.312 | 26.18 | 23.993 | 18.249 | 20.025 | 14.904 | 16.588 | 18.597 | 13.104 | 13.082 | 16.459 | 14.55 | 9.876 | 13.268 | 9.116 | 11.253 | 8.632 | 8.494 | 11.388 | 12.674 | 0 | 19.586 | 0 | 6.218 | 0 | 0 |
| General & Administrative Expenses
| -6.481 | 38.7 | -52.977 | 84.359 | -1.923 | 30.094 | -73.04 | 101.626 | -16.018 | 34.98 | -46.721 | 68.829 | -8.627 | 25.675 | -27.67 | 21.71 | -8.519 | 19.203 | -29.75 | 18.921 | -8.946 | 17.111 | -22.351 | 12.638 | -11.271 | 20.721 | -36.651 | 22.289 | -10.418 | 17.555 | -25.874 | 17.895 | -9.236 | 14.564 | -21.109 |
| Selling & Marketing Expenses
| 181.369 | 150.011 | 124.75 | 138.779 | 137.812 | 133.966 | 120.718 | 140.63 | 106.833 | 95.253 | 88.076 | 96.757 | 85.092 | 68.346 | 81.08 | 80.984 | 47.845 | 34.305 | 49.301 | 56.12 | 62.297 | 51.564 | 43.1 | 56.957 | 53.011 | 40.331 | 34.556 | 32.941 | 29.506 | 36.828 | 32.655 | 39.622 | 30.989 | 28.301 | 32.136 |
| SG&A
| 174.888 | 187.522 | 160.384 | 223.138 | 135.89 | 164.06 | 47.678 | 242.256 | 90.815 | 130.232 | 41.355 | 165.586 | 76.465 | 94.021 | 53.409 | 102.694 | 39.327 | 53.509 | 19.551 | 75.041 | 53.352 | 68.675 | 20.748 | 69.595 | 41.74 | 61.052 | -2.094 | 55.23 | 19.087 | 54.383 | 6.781 | 57.517 | 21.753 | 42.865 | 11.027 |
| Other Expenses
| -261.127 | 1.761 | -5.541 | -0.903 | -7.233 | -2.409 | 80.003 | -55.866 | 53.646 | 2.782 | 2.574 | -3.791 | -3.317 | -0.322 | -0.671 | -1.004 | -0.517 | -1.004 | -0.845 | -0.043 | -1.04 | 0.057 | -1.371 | 0.5 | 26.399 | -7.11 | -0.283 | -0.258 | -0.521 | 0.718 | 3.275 | 0.375 | 6.87 | 0.475 | 17.844 |
| Operating Expenses
| 261.127 | 223.83 | 209.122 | 224.612 | 228.203 | 190.334 | 182.848 | 226.239 | 172.747 | 155.326 | 147.686 | 155.788 | 133.023 | 116.171 | 119.803 | 120.719 | 80.817 | 66.333 | 86.045 | 91.478 | 93.173 | 79.767 | 71.547 | 81.079 | 79.392 | 62.575 | 57.129 | 56.15 | 45.122 | 56.757 | 52.252 | 59.132 | 40.885 | 44.174 | 45.633 |
| Operating Income
| 152.711 | 38.377 | 57.118 | 110.533 | 78.417 | 22.867 | -2.492 | 99.393 | 65.243 | 87.959 | 48.438 | 97.328 | 60.92 | 41.712 | 41.534 | 47.686 | 26.83 | -10.313 | 6.354 | 25.669 | 4.415 | 1.25 | -0.676 | 15.904 | -0.595 | -3.108 | -3.399 | 15.756 | 24.381 | 9.408 | 7.598 | 15.091 | 22.26 | 8.542 | -5.453 |
| Operating Income Ratio
| 0.286 | 0.111 | 0.159 | 0.264 | 0.197 | 0.08 | -0.01 | 0.246 | 0.218 | 0.291 | 0.188 | 0.316 | 0.239 | 0.201 | 0.189 | 0.205 | 0.174 | -0.125 | 0.048 | 0.162 | 0.031 | 0.011 | -0.007 | 0.118 | -0.005 | -0.035 | -0.043 | 0.16 | 0.254 | 0.109 | 0.096 | 0.16 | 0.256 | 0.109 | -0.088 |
| Total Other Income Expenses Net
| 5.958 | 3.279 | 5.183 | -0.903 | -7.233 | -0.989 | -1.254 | -0.679 | -12.248 | -2.203 | 2.574 | 1.893 | -6.669 | -1.899 | -4.239 | -5.668 | -2.135 | -1.397 | -4.681 | -2.118 | -3.33 | -0.978 | -2.047 | -2.501 | -0.47 | -1.068 | -1.423 | -1.174 | -1.381 | -1.093 | 2.572 | 1.25 | 4.181 | -2.071 | 14.784 |
| Income Before Tax
| 158.669 | 41.656 | 62.302 | 109.63 | 71.184 | 21.878 | -3.746 | 98.714 | 52.995 | 85.756 | 51.012 | 93.537 | 57.603 | 41.39 | 40.863 | 46.682 | 26.314 | -11.317 | 5.509 | 25.627 | 3.374 | 1.306 | -2.047 | 16.404 | -0.08 | -3.108 | -3.552 | 15.498 | 23.763 | 10.126 | 10.872 | 15.466 | 29.129 | 9.015 | 12.298 |
| Income Before Tax Ratio
| 0.297 | 0.12 | 0.174 | 0.261 | 0.178 | 0.076 | -0.015 | 0.245 | 0.177 | 0.284 | 0.198 | 0.304 | 0.226 | 0.2 | 0.186 | 0.201 | 0.171 | -0.137 | 0.042 | 0.161 | 0.024 | 0.012 | -0.022 | 0.122 | -0.001 | -0.035 | -0.045 | 0.157 | 0.247 | 0.117 | 0.137 | 0.164 | 0.336 | 0.115 | 0.198 |
| Income Tax Expense
| 24.098 | 6.907 | 4.597 | 15.053 | 2.779 | 2.528 | -12.592 | 16.509 | 6.53 | 11.587 | 11.157 | 12.266 | 7.165 | 3.846 | 2.464 | 5.62 | 0.352 | 0.645 | 0.085 | 4.465 | 0.35 | 1.406 | -0.675 | 2.632 | -1.742 | -1.617 | -0.131 | 2.323 | 3.604 | 1.601 | 1.97 | 2.132 | 4.569 | 1.533 | 1.779 |
| Net Income
| 134.571 | 34.749 | 57.705 | 94.577 | 68.405 | 19.349 | 8.846 | 82.205 | 46.464 | 74.169 | 38.628 | 75.936 | 46.932 | 33.206 | 34.244 | 38.42 | 25.75 | -10.435 | 7.343 | 22.825 | 4.663 | 1.062 | 0.462 | 15.079 | 0.677 | -2.559 | -2.421 | 13.175 | 20.158 | 8.525 | 8.902 | 13.335 | 24.561 | 7.482 | 10.519 |
| Net Income Ratio
| 0.252 | 0.1 | 0.161 | 0.226 | 0.171 | 0.068 | 0.036 | 0.204 | 0.156 | 0.246 | 0.15 | 0.247 | 0.184 | 0.16 | 0.156 | 0.165 | 0.167 | -0.126 | 0.055 | 0.144 | 0.033 | 0.01 | 0.005 | 0.112 | 0.006 | -0.029 | -0.031 | 0.134 | 0.21 | 0.098 | 0.112 | 0.142 | 0.283 | 0.095 | 0.169 |
| EPS
| 0.77 | 0.28 | 0.46 | 0.76 | 0.55 | 0.16 | 0.071 | 0.93 | 0.53 | 0.84 | 0.45 | 0.91 | 0.57 | 0.4 | 0.42 | 0.47 | 0.32 | -0.13 | 0.09 | 0.28 | 0.044 | 0.01 | 0.001 | 0.02 | 0.008 | -0.03 | -0.03 | 0.16 | 0.26 | 0.11 | 0.15 | 0.22 | 0.39 | 0.12 | 0.17 |
| EPS Diluted
| 0.77 | 0.28 | 0.46 | 0.76 | 0.55 | 0.16 | 0.071 | 0.93 | 0.53 | 0.84 | 0.45 | 0.91 | 0.57 | 0.4 | 0.42 | 0.47 | 0.32 | -0.13 | 0.09 | 0.28 | 0.044 | 0.01 | 0.001 | 0.02 | 0.008 | -0.03 | -0.029 | 0.16 | 0.26 | 0.11 | 0.15 | 0.22 | 0.39 | 0.12 | 0.17 |
| EBITDA
| 179.038 | 39.312 | 80.812 | 110.161 | 72.139 | 28.351 | -2.451 | 100.406 | 54.632 | 87.08 | 53.581 | 90.971 | 60.815 | 42.78 | 44.336 | 51.224 | 27.819 | -10.903 | 9.378 | 27.689 | 5.62 | 2.339 | -1.359 | 19.38 | 0.433 | -1.607 | -3.71 | 16.924 | 24.444 | 12.135 | 30.355 | 24.138 | 31.774 | 11.615 | 12.854 |
| EBITDA Ratio
| 0.335 | 0.114 | 0.225 | 0.263 | 0.181 | 0.099 | -0.01 | 0.249 | 0.183 | 0.288 | 0.208 | 0.295 | 0.238 | 0.206 | 0.202 | 0.22 | 0.181 | -0.132 | 0.071 | 0.174 | 0.04 | 0.021 | -0.014 | 0.144 | 0.004 | -0.018 | -0.047 | 0.172 | 0.254 | 0.14 | 0.382 | 0.256 | 0.366 | 0.148 | 0.207 |